First National Bank Sioux Falls’s West Pharmaceutical WST Stock Holding History

First National Bank Sioux Falls’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28M	Hold	4,727	–	–	0.35%	46
2026 Q1	$1.28M	Hold	4,727	–	–	0.35%	46
2025 Q4	$1.3M	Hold	4,727	–	–	0.39%	45
2025 Q3	$1.24M	Hold	4,727	–	–	0.39%	46
2025 Q2	$1.03M	Buy	4,727 +2,592	+121%	+$554K	0.38%	49
2025 Q1	$478K	Buy	+2,135	New	+$588K	0.19%	83

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

First National Bank Sioux Falls's WST Position: Q2 2026 in Review

First National Bank Sioux Falls held its West Pharmaceutical (WST) position steady in Q2 2026 at 4,727 shares worth $1.28M. The position accounts for 0.35% of the portfolio, ranked #46.

First National Bank Sioux Falls first reported a position in WST in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.3M in Q4 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

First National Bank Sioux Falls held 4,727 shares of West Pharmaceutical worth $1.28M as of Q2 2026.
First National Bank Sioux Falls left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 0.35% of First National Bank Sioux Falls's portfolio in Q2 2026, its #46 holding.
First National Bank Sioux Falls first reported a position in West Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
First National Bank Sioux Falls's West Pharmaceutical position peaked at $1.3M in Q4 2025.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on First National Bank Sioux Falls's 13F filing for Q2 2026, filed 24 Jul 2026.